China SXT Pharmaceuticals
SXTC
SXTC
5 hedge funds and large institutions have $66K invested in China SXT Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$35K |
2 |
HF
2
HRT Financial
New York
|
$8K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$6K |
Top Sellers
1 |
VF
1
Virtu Financial
New York
|
$0 |
2 |
2
Renaissance Technologies
New York
|
$17K |